Gene · 4818
Papers1,677
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,677
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multiomics integration analysis identifies tumor cell-derived MIF as a therapeutic target and potentiates anti-PD-1 therapy in osteosarcoma. | J Immunother Cancer | 2025 | 40846326 | PubTator, text mining | PubMed |
| Natural killer cell granule protein 7 contributes to CD8+ T cell-mediated platelet apoptosis in immune thrombocytopenia. | Res Pract Thromb Haemost | 2025 | 40837024 | PubTator, text mining | PubMed |
| Anoikis-related genes predicts prognosis and therapeutic response in renal cell carcinoma. | Ann Med | 2025 | 40830065 | PubTator, text mining | PubMed |
| Cytotoxic granules and effector molecules from immune cells in tuberculosis: Mechanisms of host defense and therapeutic potential. | Virulence | 2025 | 40825006 | PubTator, text mining | PubMed |
| A Dual Role for NKG7 in T-cell Cytotoxicity and Longevity. | Cancer Immunol Res | 2025 | 40824199 | PubTator, text mining | PubMed |
| NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer. | Front Immunol | 2025 | 40821787 | PubTator, text mining | PubMed |
| Unraveling NK cell heterogeneity through single-cell sequencing: insights from physiological and tumor contexts for clinical applications. | Front Immunol | 2025 | 40761786 | PubTator, text mining | PubMed |
| Nanoparticle-Delivered siRNA Targeting NSUN4 Relieves Systemic Lupus Erythematosus through Declining Mitophagy-Mediated CD8+T Cell Exhaustion. | MedComm (2020) | 2025 | 40761479 | PubTator, text mining | PubMed |
| Identification of IQGAP3 prognostic potential and involvement in immune cell infiltration in LUAD. | Eur J Med Res | 2025 | 40760442 | PubTator, text mining | PubMed |
| Semi-supervised contrastive learning variational autoencoder Integrating single-cell multimodal mosaic datasets. | BMC Bioinformatics | 2025 | 40759922 | PubTator, text mining | PubMed |
| TLR4+group 2 innate lymphoid cells contribute to persistent type 2 immunity in airway diseases. | Nat Commun | 2025 | 40753172 | PubTator, text mining | PubMed |
| Integrative bioinformatics analysis and experimental validation identify CHEK1 as an unfavorable prognostic biomarker related to immunosuppressive phenotypes in soft tissue sarcomas. | NPJ Precis Oncol | 2025 | 40751074 | PubTator, text mining | PubMed |
| Uncovering the molecular mechanisms of Qingdu Zengye Decoction in the treatment of nasopharyngeal carcinoma: an integrative investigation. | Front Pharmacol | 2025 | 40746726 | PubTator, text mining | PubMed |
| Integrative network pharmacology and multi-omics reveal anisodamine hydrobromide's multi-target mechanisms in sepsis. | Sci Rep | 2025 | 40744980 | PubTator, text mining | PubMed |
| Integrated system for screening tumor-specific TCRs, epitopes, and HLA subtypes using single-cell sequencing data. | J Immunother Cancer | 2025 | 40744664 | PubTator, text mining | PubMed |
| Integrative spatial and single-cell transcriptomics elucidate programmed cell death-driven tumor microenvironment dynamics in hepatocellular carcinoma. | Front Immunol | 2025 | 40740783 | PubTator, text mining | PubMed |
| Comprehensive insight on immune landscape in intracerebral hemorrhage patients with single-cell RNA sequencing: from blood to hematoma. | J Neuroinflammation | 2025 | 40739271 | PubTator, text mining | PubMed |
| Engineering Innate Immunity: Recent Advances and Future Directions for CAR-NK and CAR-Macrophage Therapies in Solid Tumors. | Cancers (Basel) | 2025 | 40723278 | PubTator, text mining | PubMed |
| A multi-omic single-cell landscape reveals transcription and epigenetic regulatory features of t(8;21) AML. | J Transl Med | 2025 | 40707954 | PubTator, text mining | PubMed |
| Prediction of genomic biomarkers for endometriosis using the transcriptomic dataset. | World J Clin Cases | 2025 | 40671745 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4818/papers?page=6